Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases

References

• Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature466(7308), 835–840 (2010).
   PubMed Web of Science ®Google Scholar
• Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the microprocessor complex. Nature432(7014), 231–235 (2004).
   PubMed Web of Science ®Google Scholar
• Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha–DGCR8 complex in primary microRNA processing. Genes Dev.18(24), 3016–3027 (2004).
   PubMed Web of Science ®Google Scholar
• Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science303(5654), 95–98 (2004).
   PubMed Web of Science ®Google Scholar
• Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol.6(5), 376–385 (2005).
   PubMed Web of Science ®Google Scholar
• Weinmann L, Hock J, Ivacevic T et al. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell136(3), 496–507 (2009).
   PubMed Web of Science ®Google Scholar
• Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5’ UTR as in the 3’ UTR. Proc. Natl Acad. Sci. USA104(23), 9667–9672 (2007).
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell128(6), 1105–1118 (2007).
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature460(7254), 529–533 (2009).
   PubMed Web of Science ®Google Scholar
• Leung A, Calabrese JM, Sharp PA. Quantitative analysis of Argonuate protein reveals microRNA-dependent localization to stress granules. Proc. Natl Acad. Sci. USA103(48), 18125–18130 (2006).
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity34(5), 637–650 (2011).
   PubMed Web of Science ®Google Scholar
• Martin TR, Frevert CW. Innate immunity in the lungs. Proc. Am. Thorac. Soc.2(5), 403–411 (2005).
   PubMedGoogle Scholar
• Greene CM, McElvaney NG. Toll-like receptor expression and function in airway epithelial cells. Arch. Immunol. Ther. Exp. (Warsz)53(5), 418–427 (2005).
   PubMed Web of Science ®Google Scholar
• Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science303(5654), 83–86 (2004).
   PubMed Web of Science ®Google Scholar
• Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell136(1), 26–36 (2009).
   PubMed Web of Science ®Google Scholar
• Xiao C, Calado DP, Galler G et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell131(1), 146–159 (2007).
   PubMed Web of Science ®Google Scholar
• Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr. Opin. Hematol.15(4), 352–358 (2008).
   PubMed Web of Science ®Google Scholar
• Vigorito E, Perks KL, Abreu-Goodger C et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity27(6), 847–859 (2007).
   PubMed Web of Science ®Google Scholar
• Wang P, Hou J, Lin L et al. Inducible microRNA-155 feedback promotes Type 1 IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol.185(10), 6226–6233 (2010).
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl Acad. Sci. USA106(17), 7113–7118 (2009).
   PubMed Web of Science ®Google Scholar
• Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol.182(5), 2578–2582 (2009).
   PubMed Web of Science ®Google Scholar
• Tang B, Xiao B, Liu Z et al. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett.584(8), 1481–1486 (2010).
   PubMed Web of Science ®Google Scholar
• Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J. Investig. Med.58(8), 961–967 (2010).
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille JJ, Cimino A et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol.179(8), 5082–5089 (2007).
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA104(5), 1604–1609 (2007).
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA103(33), 12481–12486 (2006).
   PubMed Web of Science ®Google Scholar
• Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol.180(8), 5689–5698 (2008).
   PubMed Web of Science ®Google Scholar
• Chen XM, Splinter PL, O’Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem.282(39), 28929–28938 (2007).
   PubMed Web of Science ®Google Scholar
• Johnnidis JB, Harris MH, Wheeler RT et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature451(7182), 1125–1129 (2008).
   PubMed Web of Science ®Google Scholar
• Androulidaki A, Iliopoulos D, Arranz A et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity31(2), 220–231 (2009).
   PubMed Web of Science ®Google Scholar
• Hou J, Wang P, Lin L et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type 1 IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol.183(3), 2150–2158 (2009).
   PubMed Web of Science ®Google Scholar
• Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu ZG. MicroRNAs modulate the noncanonical transcription factor NF-κB pathway by regulating expression of the kinase IKKα during macrophage differentiation. Nat. Immunol.11(9), 799–805 (2010).
   PubMed Web of Science ®Google Scholar
• Chen R, Alvero AB, Silasi DA et al. Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene27(34), 4712–4723 (2008).
   PubMed Web of Science ®Google Scholar
• Bazzoni F, Rossato M, Fabbri M et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl Acad. Sci. USA106(13), 5282–5287 (2009).
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell139(4), 693–706 (2009).
   PubMed Web of Science ®Google Scholar
• Sharma A, Kumar M, Aich J et al. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc. Natl Acad. Sci. USA106(14), 5761–5766 (2009).
   PubMedGoogle Scholar
• Ma F, Liu X, Li D et al. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol.184(11), 6053–6059 (2010).
   PubMed Web of Science ®Google Scholar
• Greene CM, Branagan P, McElvaney NG. Toll-like receptors as therapeutic targets in cystic fibrosis. Expert Opin. Ther. Targets12(12), 1481–1495 (2008).
   PubMed Web of Science ®Google Scholar
• Greene CM, McElvaney NG. Proteases and antiproteases in chronic neutrophilic lung disease – relevance to drug discovery. Br. J. Pharmacol.158(4), 1048–1058 (2009).
   PubMed Web of Science ®Google Scholar
• Greene CM. How can we target pulmonary inflammation in cystic fibrosis? Open. Respir. Med. J.4, 18–19 (2010).
   PubMedGoogle Scholar
• Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease – master regulators or target practice? Respir. Res.11, 148 (2010).
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Bray IM, Chotirmall SH et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J. Immunol.184(4), 1702–1709 (2010).
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Balakathiresan NS, Dalgard C et al. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J. Biol. Chem.286(13), 11604–11615 (2011).
   PubMed Web of Science ®Google Scholar
• Finn PW, Bigby TD. Innate immunity and asthma. Proc. Am. Thorac. Soc.6(3), 260–265 (2009).
   PubMedGoogle Scholar
• Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J. Immunol.182(8), 4994–5002 (2009).
   PubMed Web of Science ®Google Scholar
• Lu TX, Hartner J, Lim EJ et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-{γ} pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol.187(6), 3362–3373 (2011).
   PubMed Web of Science ®Google Scholar
• Collison A, Herbert C, Siegle JS, Mattes J, Foster PS, Kumar RK. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm. Med.23(11), 29–34 (2011).
   Google Scholar
• Kumar M, Ahmad T, Sharma A et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J. Allergy Clin. Immunol.128(5), 1077–1085; e10 (2011).
   PubMed Web of Science ®Google Scholar
• Liu X, Nelson A, Wang X et al. MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis. Biochem. Biophys. Res. Commun.380(1), 177–182 (2009).
   PubMed Web of Science ®Google Scholar
• Hutvagner G, Simard MJ, Mello CC, Zamore PD. Sequence-specific inhibition of small RNA function. PLoS Biol.2(4), E98 (2004).
   PubMed Web of Science ®Google Scholar
• Garofalo M, Croce CM. microRNAs: master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. Toxicol.51, 25–43 (2011).
   PubMed Web of Science ®Google Scholar
• Elmen J, Lindow M, Schutz S et al. LNA-mediated microRNA silencing in non-human primates. Nature452(7189), 896–899 (2008).
   PubMed Web of Science ®Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature438(7068), 685–689 (2005).
   PubMed Web of Science ®Google Scholar
• Henry JC, Azevedo-Pouly AC, Schmittgen TD. microRNA replacement therapy for cancer. Pharm. Res.28(12), 3030-42 (2011).
   PubMed Web of Science ®Google Scholar
• Lam JK, Liang W, Chan HK. Pulmonary delivery of therapeutic siRNA. Adv. Drug Deliv. Rev. doi:10.1016/j.addr.2011.02.006 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov.9(10), 775–789 (2010).
   PubMed Web of Science ®Google Scholar
• Castanotto D, Sakurai K, Lingeman R et al. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res.35(15), 5154–5164 (2007).
   PubMed Web of Science ®Google Scholar
• Grimm D, Streetz KL, Jopling CL et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature441(7092), 537–541 (2006).
   PubMed Web of Science ®Google Scholar
• Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl Acad. Sci. USA102(37), 13212–13217 (2005).
   PubMed Web of Science ®Google Scholar
• Chung KH, Hart CC, Al-Bassam S et al. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res.34(7), e53 (2006).
   PubMed Web of Science ®Google Scholar
• Chen S, Ni M, Yu B, Lv T, Lu M, Gong F. Construction and identification of a human liver specific microRNA eukaryotic expression vector. Cell Mol. Immunol.4(6), 473–477 (2007).
   PubMedGoogle Scholar
• Ibrahim AF, Weirauch U, Thomas M, Grunweller A, Hartmann RK, Aigner A. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res.71(15), 5214–5224 (2011).
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science327(5962), 198–201 (2010).
   PubMed Web of Science ®Google Scholar
• Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J. Gastroenterol.15(45), 5633–5640 (2009).
   PubMed Web of Science ®Google Scholar
• Liu XQ, Song WJ, Sun TM, Zhang PZ, Wang J. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles. Mol. Pharm.8(1), 250–259 (2011).
   PubMedGoogle Scholar
• Wu SY, McMillan NA. Lipidic systems for in vivo siRNA delivery. AAPS J.11(4), 639–652 (2009).
   PubMed Web of Science ®Google Scholar
• Brower V. RNA interference advances to early-stage clinical trials. J. Natl Cancer Inst.102(19), 1459–1461 (2010).
   PubMed Web of Science ®Google Scholar
• Nielsen EJ, Nielsen JM, Becker D et al. Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles. Pharm. Res.27(12), 2520–2527 (2010).
   PubMed Web of Science ®Google Scholar
• Moschos SA, Jones SW, Perry MM et al. Lung delivery studies using siRNA conjugated to TAT(48–60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug. Chem.18(5), 1450–1459 (2007).
   PubMed Web of Science ®Google Scholar
• Moschos SA, Williams AE, Lindsay MA. Cell-penetrating-peptide-mediated siRNA lung delivery. Biochem. Soc. Trans.35(Pt 4), 807–810 (2007).
   PubMedGoogle Scholar
• Oh SY, Ju Y, Kim S, Park H. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent. Oligonucleotides20(5), 225–230 (2010).
   PubMed Web of Science ®Google Scholar
• Baker M. RNA interference: homing in on delivery. Nature464(7292), 1225–1228 (2010).
   Google Scholar
• Starczynowski DT, Kuchenbauer F, Argiropoulos B et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat. Med.16(1), 49–58 (2010).
   PubMed Web of Science ®Google Scholar
• Ceppi M, Pereira PM, Dunand-Sauthier I et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl Acad. Sci. USA106(8), 2735–2740 (2009).
   PubMed Web of Science ®Google Scholar
• Tan Z, Randall G, Fan J et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum Genet.81(4), 829–834 (2007).
   PubMed Web of Science ®Google Scholar
• Sheedy FJ, Palsson-McDermott E, Hennessy EJ et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol.11(2), 141–147 (2010).
   PubMed Web of Science ®Google Scholar
• Mattes J, Collison A, Plank M, Phipps S, Foster PS. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl Acad. Sci. USA106(44), 18704–18709 (2009).
   PubMed Web of Science ®Google Scholar
• Garbacki N, Di Valentin E, Huynh-Thu VA et al. MicroRNAs profilling in murine models of acute and chronic asthma: a relationship with mRNA targets. PLoS One28(6), e16509 (2011).
   Google Scholar
• Wang H, Garzon R, Sun H et al. NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell14(5), 369–381 (2008).
   PubMed Web of Science ®Google Scholar
• Chiba Y, Tanabe M, Goto K, Sakai H, Misawa M. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am. J. Respir. Crit. Care Med.180(8), 713–719 (2009).
   PubMed Web of Science ®Google Scholar
• Kuhn AR, Schlauch K, Lao R, Halayko AJ, Gerthoffer WT, Singer CA. MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am. J. Respir. Cell Mol. Biol.42(4), 506–513 (2010).
   PubMed Web of Science ®Google Scholar
• Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3β. J. Biol. Chem.285(38), 29336–29347 (2010).
   PubMed Web of Science ®Google Scholar
• Li YJ, Zhang YX, Wang PY et al. Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol. Rep.27(1), 129–134 (2011).
   PubMedGoogle Scholar
• Liang S, He L, Zhao X et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One6(4), e18409 (2011).
   PubMed Web of Science ®Google Scholar
• Yan D, Ng WL, Zhang X et al. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One5(7), e11397 (2010).
   PubMed Web of Science ®Google Scholar
• Trang P, Medina PP, Wiggins JF et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene29(11), 1580–1587 (2010).
   PubMed Web of Science ®Google Scholar
• Kim SJ, Oh JS, Shin JY et al. Development of microRNA-145 for therapeutic application in breast cancer. J. Cont. Release (2011).
   Google Scholar
• Borel F, van Logtenstein R, Koornneef A et al.In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs. J. RNAi Gene Silencing7, 434–442 (2011).
   PubMedGoogle Scholar
• Montgomery RL, Hullinger TG, Semus HM et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation124(14), 1537–1547 (2011).
   PubMed Web of Science ®Google Scholar
• Ma L, Reinhardt F, Pan E et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol.28(4), 341–347 (2010).
   PubMed Web of Science ®Google Scholar
• Xu H, Liu YL, Yang YM, Dong XS. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth. Int. J. Colorectal. Dis.27(1), 21–30 (2011).
   PubMedGoogle Scholar
• Hibbitt O, Agkatsev S, Owen C et al. RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo. Gene Ther. doi:10.1038/gt.2011.103 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Mao CP, He L, Tsai YC et al.In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination. Cell Biosci.1(1), 3 (2011).
   PubMedGoogle Scholar
• Takeshita F, Patrawala L, Osaki M et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther.18(1), 181–187 (2010).
   PubMed Web of Science ®Google Scholar
• Su J, Baigude H, McCarroll J, Rana TM. Silencing microRNA by interfering nanoparticles in mice. Nucleic Acids Res.39(6), e38 (2011).
   PubMed Web of Science ®Google Scholar
• Hwang do W, Son S, Jang J et al. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials32(21), 4968–4975 (2011).
   PubMed Web of Science ®Google Scholar
• Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science318(5848), 271–274 (2007).
   PubMed Web of Science ®Google Scholar